What Volfenac Gel Treats: Main Uses and Benefits

Volfenac Gel (diclofenac sodium topical gel) is applied to the skin to address symptoms related to physical discomfort and inflammatory or irritative states. The primary therapeutic focus is on conditions presenting with systemic or localized discomfort in musculoskeletal areas.

The medicine is commonly used across conditions presenting with acute episodes, specifically for the relief of pain in osteoarthritis affecting joints suitable for topical treatment, such as the knees and those of the hands.

The gel may be part of symptomatic management in clinical settings that involve acute or unstable symptom patterns, such as when managing osteoarthritis pain or providing short-term symptomatic assistance for acute soft tissue injuries. This approach generally contributes to improved comfort during periods of heightened symptoms. This supportive relief helps ease the overall symptom burden and may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for symptoms related to physical discomfort

Regulatory References

1. NIH DailyMed Prescribing Information

Volfenac Gel (diclofenac topical) is generally for use in adults and adolescents 14 years and over. However, regulatory documents define specific populations who should not use this medicine.

Populations Not Eligible for Use

Classification	Who Should Not Use Volfenac Gel
Contraindicated	Patients with a known hypersensitivity to diclofenac, aspirin, or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) who have experienced asthma, hives, or allergic-type reactions in the past. It is also prohibited for use in the setting of coronary artery bypass graft (CABG) surgery and during the third trimester of pregnancy (after 30 weeks gestation).
Use is Restricted	The gel must not be applied to open wounds, damaged or non-intact skin (e.g., eczema, infections, burns), or on mucous membranes.
Requires Caution	Use should be approached cautiously and may be avoided in patients with severe heart failure, advanced renal disease, or a recent myocardial infarction (MI), unless the benefits clearly outweigh the risks of worsening these conditions. Monitoring is recommended for elderly patients and those with reduced liver, heart, or kidney function.

For pregnancy, use in the first and second trimesters is generally not recommended unless clearly necessary. It is also not recommended for women who are breast-feeding without professional advice. The drug is contraindicated for children under 14 years.

Interactions with other medicines and products

Official regulatory documents describe a set of necessary constraints and potential systemic risks associated with the use of diclofenac topical gel, focusing on combinations with other medications and procedural requirements.

Systemic Interaction Constraints

The primary concerns involve the risk of systemic absorption leading to drug-drug interactions, even with topical application. Combinations that are not generally recommended include co-administration with analgesic doses of aspirin and with other oral non-steroidal anti-inflammatory drugs (NSAIDs), due to the potential for increased gastrointestinal adverse effects and bleeding risk.

Patients using anticoagulants, antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), or serotonin norepinephrine reuptake inhibitors (SNRIs) have an increased risk of serious bleeding when using this product. The gel may diminish the blood pressure-lowering effect of certain antihypertensives (e.g., ACE inhibitors, ARBs, Beta-blockers) and may reduce the natriuretic effect of diuretics (e.g., furosemide, thiazides).

Concomitant use can also increase the serum concentrations of drugs such as Lithium and Digoxin.

Procedural and Local Constraints

Specific constraints regarding application must be followed to avoid reduced efficacy or local interaction. The treated area should not be washed for at least one hour after application, and clothing or gloves should be avoided for at least 10 minutes. The application site must not be exposed to natural or artificial sunlight. Furthermore, the use of other topical products (including sunscreens, lotions, or cosmetics) on the same site should be avoided until the gel is dry.

Targeted Inhibition of Prostaglandin Synthesis

The mechanism of action involves the active ingredient, Diclofenac, acting as a competitive inhibitor of the Cyclooxygenase-2 (COX-2) enzyme. This molecular blockade stops the conversion of arachidonic acid into pro-inflammatory mediators, primarily Prostaglandin E2 ( PGE2) . By suppressing PGE2 production, the gel's mechanism attenuates the local humoral pathway responsible for PGE2 synthesis and nociceptor sensitization.

---

Peripheral Desensitization of Pain Receptors

The physiological consequence of reduced PGE2 is the prevention of peripheral sensitization, where PGE2 normally lowers the activation threshold of peripheral nerve endings (nociceptors). By maintaining the nerve's normal firing threshold, the mechanism maintains the normal activation threshold of the peripheral nociceptive pathway. This localized physiological change contributes directly to a reduction in peripheral nociceptor signaling and attenuates prostaglandin-mediated increases in local vascular permeability (edema).

---

Constraint by Local Tissue Penetration

The mechanism operates strictly within a localized context, depending on the drug's ability to achieve sufficient inhibitory concentration in the affected tissue. This constraint means the resulting physiological effect is concentrated in superficial tissues, tendons, and adjacent joints, ensuring the drug’s action is tightly regulated within peripheral pathways rather than altering systemic responses.

How to Use Volfenac Gel (Diclofenac Topical Gel)

The medicine is for external use only and is applied to the skin over the affected joint.

Official Dosing and Frequency

Joint Location	Dose per Application	Frequency
Lower Extremity (Knee, Ankle, Foot)	4 grams (g)	4 times daily
Upper Extremity (Hand, Wrist, Elbow)	2 grams (g)	4 times daily

Maximum Daily Total: The total amount of gel used across all treated joints must not exceed 32 grams per day.

Application Procedure and Special Conditions

1. Measure the Dose: The prescribed amount of gel (2g or 4g) must be accurately measured using the dosing card supplied with the product.
2. Application: Gently rub the measured gel into the clean, dry, intact skin covering the entire affected joint.
3. Hand Hygiene: Wash hands thoroughly immediately after application, unless the hands are the joint being treated. If treating the hands, do not wash them for at least one hour after application.
4. Restrictions: Do not wash or bathe the treated joint for at least one hour after application. Wait at least 10 minutes before covering the treated area with clothing or gloves.
5. Exclusions: Do not cover the treated area with an occlusive dressing or apply external heat. The product is not generally recommended for use in children.

Volfenac Gel: Recent Clinical Evidence

Clinical research, largely consisting of randomized controlled trials (RCTs) and systematic reviews, has focused on the use of topical diclofenac, the active ingredient in Volfenac Gel, primarily for localized pain associated with osteoarthritis (OA) and various musculoskeletal injuries.

---

Efficacy and Therapeutic Outcome

• Osteoarthritis: Studies comparing diclofenac topical gel to a non-medicated vehicle (placebo) in patients with knee and hand OA consistently reported a statistically greater improvement in pain relief and physical function scores in the diclofenac group over time (e.g., at 3–6 weeks and 8–12 weeks). The magnitude of improvement was considered moderate to high quality evidence by several meta-analyses.
• Acute Pain: For acute conditions like ankle sprains or blunt impact injuries, some research found that the topical gel demonstrated significant benefits in reducing pain and improving functional capacity compared to placebo over treatment periods of one to two weeks.

---

Safety and Comparative Profile

• Systemic Safety: Topical diclofenac formulations exhibit lower systemic absorption compared to oral NSAIDs. This profile is generally associated with a reduced incidence of systemic adverse events, such as gastrointestinal and cardiovascular effects, compared to the oral counterparts, particularly in long-term safety studies of older adults or those with comorbidities.
• Local Reactions: The most commonly observed adverse events in the research were local application-site reactions, including dry skin, rash, and itching (pruritus). These reactions were typically mild to moderate in severity and resulted in low rates of study withdrawal.
• Comparative Efficacy: Head-to-head trials suggest that the efficacy of topical diclofenac gel for pain relief in localized OA is often comparable to that of some oral NSAIDs, though with the notable difference in the systemic side effect profile.

Common questions about Volfenac Gel (FAQ)

---

Q: What is the main ingredient in Volfenac Gel?

The primary active ingredient in Volfenac Gel is diclofenac sodium, an anti-inflammatory medicine. According to the official product information, it belongs to a class of drugs called Non-Steroidal Anti-Inflammatory Drugs, or NSAIDs.

---

Q: What types of pain is Volfenac Gel used for?

Official regulatory documents state that Volfenac Gel is used for the local symptomatic treatment of pain. Specifically, it is indicated for conditions such as mild to moderate osteoarthritis of the knee and hand, and various forms of joint and muscle pain due to soft tissue injuries like sprains and strains.

---

Q: How does Volfenac Gel work to relieve pain?

Volfenac Gel works by delivering the active ingredient, diclofenac, directly into the area where it's applied. Studies and official information indicate that diclofenac helps to relieve pain and reduce inflammation by blocking the action of certain substances in the body.

---

Q: How quickly can I expect to feel relief after using Volfenac Gel?

The time it takes to feel the pain-relieving effects can vary among individuals and the condition being treated. Official information suggests relief may become noticeable after several days of continuous use. It is intended for localized and sustained relief.

---

Q: Can Volfenac Gel cause skin irritation or rashes?

Yes, regulatory documents indicate that local skin reactions are common side effects, especially at the application site. This may include symptoms such as dryness, redness, itching, or a rash. These reactions are often described as mild and temporary. Information on what to do for severe or persistent symptoms is covered in the safety section.

---

Q: Is Volfenac Gel absorbed into the bloodstream?

While Volfenac Gel is intended for local action, the active ingredient is absorbed systemically (into the bloodstream) after skin application. However, studies show that the amount absorbed is typically much lower compared to taking the same medicine by mouth. This characteristic is cited in official sources to support its use as a local treatment.

---

Q: Should I cover the area after applying Volfenac Gel?

According to the official product information, occlusive dressings (non-breathable bandages or coverings) should generally be avoided over the treated area. Covering the application site could potentially increase the amount of medicine absorbed. Official instructions specify that the gel should be massaged into the skin and allowed to dry.

Storage and Disposal Requirements

Official regulatory information for Volfenac Gel (Diclofenac Sodium Topical Gel) dictates strict rules for storage, handling, and disposal.

Requirement Area	Official Statement Summary
Storage Temperature	Store at controlled room temperature, typically 20 C to 25 C.
Prohibited Conditions	Must be protected from freezing. Avoid conditions that may lead to light exposure.
Stability/Handling	Keep the product out of the reach of children. Use within a specified period (e.g., 6 months) after first opening.
Disposal Rules	Dispose of expired or unused product properly; follow local authority guidance (e.g., drug take-back programs). Regulatory documents caution against releasing the medication into the environment.

This structure ensures the gel maintains stability throughout its shelf life and promotes safe environmental handling.